- Home
- CRDF vs LNZA Comparison
CRDF vs LNZA Comparison
Compare CRDF & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- LNZA
- Stock Information
- Founded
- CRDF 1999
- LNZA 2005
- Country
- CRDF United States
- LNZA United States
- Employees
- CRDF N/A
- LNZA N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- LNZA Major Chemicals
- Sector
- CRDF Health Care
- LNZA Industrials
- Exchange
- CRDF Nasdaq
- LNZA Nasdaq
- Market Cap
- CRDF 195.6M
- LNZA 199.8M
- IPO Year
- CRDF N/A
- LNZA N/A
- Fundamental
- Price
- CRDF $2.85
- LNZA $0.17
- Analyst Decision
- CRDF Strong Buy
- LNZA Hold
- Analyst Count
- CRDF 4
- LNZA 2
- Target Price
- CRDF $12.00
- LNZA $2.00
- AVG Volume (30 Days)
- CRDF 1.6M
- LNZA 4.9M
- Earning Date
- CRDF 05-01-2025
- LNZA 04-15-2025
- Dividend Yield
- CRDF N/A
- LNZA N/A
- EPS Growth
- CRDF N/A
- LNZA N/A
- EPS
- CRDF N/A
- LNZA N/A
- Revenue
- CRDF $683,000.00
- LNZA $49,592,000.00
- Revenue This Year
- CRDF N/A
- LNZA N/A
- Revenue Next Year
- CRDF N/A
- LNZA $77.26
- P/E Ratio
- CRDF N/A
- LNZA N/A
- Revenue Growth
- CRDF 39.96
- LNZA N/A
- 52 Week Low
- CRDF $2.01
- LNZA $0.14
- 52 Week High
- CRDF $5.64
- LNZA $3.26
- Technical
- Relative Strength Index (RSI)
- CRDF 41.85
- LNZA 31.83
- Support Level
- CRDF $2.36
- LNZA $0.19
- Resistance Level
- CRDF $3.04
- LNZA $0.31
- Average True Range (ATR)
- CRDF 0.24
- LNZA 0.06
- MACD
- CRDF 0.03
- LNZA 0.01
- Stochastic Oscillator
- CRDF 56.98
- LNZA 16.67
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.